Which has better earnings & valuation, CTEV or SDGR?

Schrodinger has lower revenue, but higher earnings than Claritev. Schrodinger is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Claritev $965.41M 0.70 -$284.28M -$17.01 N/A Schrodinger $255.87M 6.02 -$103.26M -$0.74 N/A

Is CTEV or SDGR more profitable?

Schrodinger has a net margin of -20.98% compared to Claritev's net margin of -28.46%. Claritev's return on equity of 0.00% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Claritev -28.46% N/A -5.76% Schrodinger -20.98% -16.37% -8.19%

Does the media prefer CTEV or SDGR?

In the previous week, Claritev had 2 more articles in the media than Schrodinger. MarketBeat recorded 11 mentions for Claritev and 9 mentions for Schrodinger. Claritev's average media sentiment score of 1.31 beat Schrodinger's score of 1.23 indicating that Claritev is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Claritev 6 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Schrodinger 6 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, CTEV or CERT?

Certara has lower revenue, but higher earnings than Claritev. Certara is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Claritev $965.41M 0.70 -$284.28M -$17.01 N/A Certara $418.84M 3.02 -$1.60M -$0.45 N/A

Is CTEV or CERT more profitable?

Certara has a net margin of -16.75% compared to Claritev's net margin of -28.46%. Certara's return on equity of 3.86% beat Claritev's return on equity. Company Net Margins Return on Equity Return on Assets Claritev -28.46% N/A -5.76% Certara -16.75% 3.86% 2.65%

Does the media refer more to CTEV or CERT?

In the previous week, Claritev had 7 more articles in the media than Certara. MarketBeat recorded 11 mentions for Claritev and 4 mentions for Certara. Certara's average media sentiment score of 1.55 beat Claritev's score of 1.31 indicating that Certara is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Claritev 6 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Certara 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has preferable valuation and earnings, GDRX or CTEV?

GoodRx has higher earnings, but lower revenue than Claritev. Claritev is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GoodRx $796.85M 1.48 $30.44M $0.04 86.25 Claritev $965.41M 0.70 -$284.28M -$17.01 N/A

Is GDRX or CTEV more profitable?

GoodRx has a net margin of 2.07% compared to Claritev's net margin of -28.46%. GoodRx's return on equity of 7.22% beat Claritev's return on equity. Company Net Margins Return on Equity Return on Assets GoodRx 2.07% 7.22% 2.53% Claritev -28.46% N/A -5.76%

Does the media refer more to GDRX or CTEV?

In the previous week, Claritev had 2 more articles in the media than GoodRx. MarketBeat recorded 11 mentions for Claritev and 9 mentions for GoodRx. Claritev's average media sentiment score of 1.31 beat GoodRx's score of 0.13 indicating that Claritev is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GoodRx 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Claritev 6 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, CTEV or TDOC?

Teladoc Health has higher revenue and earnings than Claritev. Teladoc Health is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Claritev $965.41M 0.70 -$284.28M -$17.01 N/A Teladoc Health $2.53B 0.46 -$200.32M -$0.99 N/A

Does the media favor CTEV or TDOC?

In the previous week, Teladoc Health had 3 more articles in the media than Claritev. MarketBeat recorded 14 mentions for Teladoc Health and 11 mentions for Claritev. Claritev's average media sentiment score of 1.31 beat Teladoc Health's score of 0.74 indicating that Claritev is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Claritev 6 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teladoc Health 7 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Which has stronger valuation & earnings, HSTM or CTEV?

HealthStream has higher earnings, but lower revenue than Claritev. Claritev is trading at a lower price-to-earnings ratio than HealthStream, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HealthStream $304.06M 2.86 $18.34M $0.72 41.35 Claritev $965.41M 0.70 -$284.28M -$17.01 N/A

Does the media favor HSTM or CTEV?

In the previous week, Claritev had 7 more articles in the media than HealthStream. MarketBeat recorded 11 mentions for Claritev and 4 mentions for HealthStream. Claritev's average media sentiment score of 1.31 beat HealthStream's score of 0.79 indicating that Claritev is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthStream 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Claritev 6 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Claritev (CTEV) Competitors

$39.98 +0.63 (+1.60%)

As of 03:58 PM Eastern

Compare

CTEV vs. SDGR, CERT, GDRX, TDOC, and HSTM

Should you buy Claritev stock or one of its competitors? Claritev's main competitors and comparable companies include Schrodinger (SDGR), Certara (CERT), GoodRx (GDRX), Teladoc Health (TDOC), and HealthStream (HSTM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Claritev compare to Schrodinger?

Claritev (NYSE:CTEV) and Schrodinger (NASDAQ:SDGR) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation.

Claritev has a beta of 0.88, indicating that its share price is 12% less volatile than the broader market. Comparatively, Schrodinger has a beta of 1.69, indicating that its share price is 69% more volatile than the broader market.

In the previous week, Claritev had 2 more articles in the media than Schrodinger. MarketBeat recorded 11 mentions for Claritev and 9 mentions for Schrodinger. Claritev's average media sentiment score of 1.31 beat Schrodinger's score of 1.23 indicating that Claritev is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Claritev	6 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Schrodinger	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Schrodinger has lower revenue, but higher earnings than Claritev. Schrodinger is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Claritev	$965.41M	0.70	-$284.28M	-$17.01	N/A
Schrodinger	$255.87M	6.02	-$103.26M	-$0.74	N/A

Claritev presently has a consensus price target of $44.83, indicating a potential upside of 12.14%. Schrodinger has a consensus price target of $20.50, indicating a potential downside of 1.82%. Given Claritev's stronger consensus rating and higher probable upside, equities analysts clearly believe Claritev is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Claritev	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29

Schrodinger has a net margin of -20.98% compared to Claritev's net margin of -28.46%. Claritev's return on equity of 0.00% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Claritev	-28.46%	N/A	-5.76%
Schrodinger	-20.98%	-16.37%	-8.19%

87.2% of Claritev shares are held by institutional investors. Comparatively, 79.1% of Schrodinger shares are held by institutional investors. 7.4% of Claritev shares are held by company insiders. Comparatively, 10.1% of Schrodinger shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Claritev beats Schrodinger on 9 of the 15 factors compared between the two stocks.

How does Claritev compare to Certara?

Claritev (NYSE:CTEV) and Certara (NASDAQ:CERT) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations, risk and media sentiment.

Claritev presently has a consensus price target of $44.83, indicating a potential upside of 12.14%. Certara has a consensus price target of $8.28, indicating a potential downside of 0.03%. Given Claritev's stronger consensus rating and higher possible upside, equities analysts plainly believe Claritev is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Claritev	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42

Certara has a net margin of -16.75% compared to Claritev's net margin of -28.46%. Certara's return on equity of 3.86% beat Claritev's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Claritev	-28.46%	N/A	-5.76%
Certara	-16.75%	3.86%	2.65%

Certara has lower revenue, but higher earnings than Claritev. Certara is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Claritev	$965.41M	0.70	-$284.28M	-$17.01	N/A
Certara	$418.84M	3.02	-$1.60M	-$0.45	N/A

Claritev has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market. Comparatively, Certara has a beta of 1.4, suggesting that its share price is 40% more volatile than the broader market.

87.2% of Claritev shares are owned by institutional investors. Comparatively, 74.0% of Certara shares are owned by institutional investors. 7.4% of Claritev shares are owned by company insiders. Comparatively, 1.1% of Certara shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Claritev had 7 more articles in the media than Certara. MarketBeat recorded 11 mentions for Claritev and 4 mentions for Certara. Certara's average media sentiment score of 1.55 beat Claritev's score of 1.31 indicating that Certara is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Claritev	6 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Certara	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Certara beats Claritev on 9 of the 16 factors compared between the two stocks.

How does Claritev compare to GoodRx?

GoodRx (NASDAQ:GDRX) and Claritev (NYSE:CTEV) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

GoodRx has a beta of 1.59, meaning that its stock price is 59% more volatile than the broader market. Comparatively, Claritev has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market.

GoodRx presently has a consensus target price of $4.23, indicating a potential upside of 22.53%. Claritev has a consensus target price of $44.83, indicating a potential upside of 12.14%. Given GoodRx's higher probable upside, equities analysts plainly believe GoodRx is more favorable than Claritev.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08
Claritev	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

GoodRx has higher earnings, but lower revenue than Claritev. Claritev is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.48	$30.44M	$0.04	86.25
Claritev	$965.41M	0.70	-$284.28M	-$17.01	N/A

In the previous week, Claritev had 2 more articles in the media than GoodRx. MarketBeat recorded 11 mentions for Claritev and 9 mentions for GoodRx. Claritev's average media sentiment score of 1.31 beat GoodRx's score of 0.13 indicating that Claritev is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GoodRx	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Claritev	6 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

GoodRx has a net margin of 2.07% compared to Claritev's net margin of -28.46%. GoodRx's return on equity of 7.22% beat Claritev's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.07%	7.22%	2.53%
Claritev	-28.46%	N/A	-5.76%

63.8% of GoodRx shares are owned by institutional investors. Comparatively, 87.2% of Claritev shares are owned by institutional investors. 5.9% of GoodRx shares are owned by insiders. Comparatively, 7.4% of Claritev shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

GoodRx beats Claritev on 8 of the 15 factors compared between the two stocks.

How does Claritev compare to Teladoc Health?

Claritev (NYSE:CTEV) and Teladoc Health (NYSE:TDOC) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings.

87.2% of Claritev shares are owned by institutional investors. Comparatively, 76.8% of Teladoc Health shares are owned by institutional investors. 7.4% of Claritev shares are owned by company insiders. Comparatively, 0.7% of Teladoc Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Teladoc Health has higher revenue and earnings than Claritev. Teladoc Health is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Claritev	$965.41M	0.70	-$284.28M	-$17.01	N/A
Teladoc Health	$2.53B	0.46	-$200.32M	-$0.99	N/A

Teladoc Health has a net margin of -7.13% compared to Claritev's net margin of -28.46%. Claritev's return on equity of 0.00% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Claritev	-28.46%	N/A	-5.76%
Teladoc Health	-7.13%	-12.15%	-5.83%

Claritev has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.12, suggesting that its stock price is 112% more volatile than the broader market.

In the previous week, Teladoc Health had 3 more articles in the media than Claritev. MarketBeat recorded 14 mentions for Teladoc Health and 11 mentions for Claritev. Claritev's average media sentiment score of 1.31 beat Teladoc Health's score of 0.74 indicating that Claritev is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Claritev	6 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teladoc Health	7 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Claritev presently has a consensus target price of $44.83, suggesting a potential upside of 12.14%. Teladoc Health has a consensus target price of $7.54, suggesting a potential upside of 16.56%. Given Teladoc Health's higher probable upside, analysts plainly believe Teladoc Health is more favorable than Claritev.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Claritev	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
Teladoc Health	1 Sell rating(s)	10 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25

Summary

Claritev beats Teladoc Health on 8 of the 15 factors compared between the two stocks.

How does Claritev compare to HealthStream?

HealthStream (NASDAQ:HSTM) and Claritev (NYSE:CTEV) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, profitability and media sentiment.

HealthStream has a beta of 0.44, meaning that its share price is 56% less volatile than the broader market. Comparatively, Claritev has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market.

HealthStream has a net margin of 6.60% compared to Claritev's net margin of -28.46%. HealthStream's return on equity of 6.81% beat Claritev's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthStream	6.60%	6.81%	4.64%
Claritev	-28.46%	N/A	-5.76%

HealthStream has higher earnings, but lower revenue than Claritev. Claritev is trading at a lower price-to-earnings ratio than HealthStream, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthStream	$304.06M	2.86	$18.34M	$0.72	41.35
Claritev	$965.41M	0.70	-$284.28M	-$17.01	N/A

In the previous week, Claritev had 7 more articles in the media than HealthStream. MarketBeat recorded 11 mentions for Claritev and 4 mentions for HealthStream. Claritev's average media sentiment score of 1.31 beat HealthStream's score of 0.79 indicating that Claritev is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthStream	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Claritev	6 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthStream currently has a consensus target price of $27.00, indicating a potential downside of 9.30%. Claritev has a consensus target price of $44.83, indicating a potential upside of 12.14%. Given Claritev's stronger consensus rating and higher probable upside, analysts plainly believe Claritev is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthStream	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Claritev	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

69.6% of HealthStream shares are held by institutional investors. Comparatively, 87.2% of Claritev shares are held by institutional investors. 20.4% of HealthStream shares are held by company insiders. Comparatively, 7.4% of Claritev shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Claritev beats HealthStream on 8 of the 15 factors compared between the two stocks.

Get Claritev News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CTEV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CTEV vs. The Competition

Export

Metric	Claritev	Healthcare Technology Industry	Healthcare Sector	NYSE Exchange
Market Cap	$666.88M	$1.76B	$7.21B	$23.47B
Dividend Yield	N/A	4.68%	2.54%	3.72%
P/E Ratio	N/A	21.36	273.21	29.20
Price / Sales	0.70	82.44	639.26	102.83
Price / Cash	2.55	31.95	77.20	32.44
Price / Book	-2.35	7.16	12.86	7.59
Net Income	-$284.28M	-$26.60M	$3.47B	$1.07B
7 Day Performance	6.33%	1.60%	-0.22%	-1.04%
1 Month Performance	75.50%	14.40%	8.04%	1.38%
1 Year Performance	-41.98%	-14.81%	25.08%	13.33%

Claritev Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CTEV Claritev	2.6515 of 5 stars	$39.98 +1.6%	$44.83 +12.1%	-42.9%	$666.88M	$965.41M	N/A	3,000	Positive News Insider Trade
SDGR Schrodinger	1.1653 of 5 stars	$19.70 -3.5%	$20.50 +4.1%	+6.8%	$1.51B	$255.87M	N/A	790	Positive News
CERT Certara	1.8224 of 5 stars	$8.35 -0.7%	$8.28 -0.9%	-25.3%	$1.28B	$418.84M	N/A	1,576	Positive News
GDRX GoodRx	4.4187 of 5 stars	$3.53 +0.6%	$4.23 +19.8%	-20.5%	$1.20B	$796.85M	88.27	950
TDOC Teladoc Health	3.0106 of 5 stars	$6.51 +2.4%	$7.54 +15.8%	-19.3%	$1.16B	$2.53B	N/A	5,600

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CTEV) was last updated on 9/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Claritev (CTEV) Competitors

CTEV vs. SDGR, CERT, GDRX, TDOC, and HSTM

How does Claritev compare to Schrodinger?

Summary

How does Claritev compare to Certara?

Summary

How does Claritev compare to GoodRx?

Summary

How does Claritev compare to Teladoc Health?

Summary

How does Claritev compare to HealthStream?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CTEV vs. The Competition

Claritev Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Claritev (CTEV) Competitors

CTEV vs. SDGR, CERT, GDRX, TDOC, and HSTM

How does Claritev compare to Schrodinger?

Which has more volatility and risk, CTEV or SDGR?

Does the media prefer CTEV or SDGR?

Which has better earnings & valuation, CTEV or SDGR?

Do analysts recommend CTEV or SDGR?

Is CTEV or SDGR more profitable?

Do insiders & institutionals believe in CTEV or SDGR?

Summary

How does Claritev compare to Certara?

Do analysts rate CTEV or CERT?

Is CTEV or CERT more profitable?

Which has preferable earnings & valuation, CTEV or CERT?

Which has more risk & volatility, CTEV or CERT?

Do institutionals & insiders believe in CTEV or CERT?

Does the media refer more to CTEV or CERT?

Summary

How does Claritev compare to GoodRx?

Which has more volatility and risk, GDRX or CTEV?

Do analysts prefer GDRX or CTEV?

Which has preferable valuation and earnings, GDRX or CTEV?

Does the media refer more to GDRX or CTEV?

Is GDRX or CTEV more profitable?

Do institutionals and insiders believe in GDRX or CTEV?

Summary

How does Claritev compare to Teladoc Health?

Do institutionals & insiders hold more shares of CTEV or TDOC?

Which has preferable valuation and earnings, CTEV or TDOC?

Is CTEV or TDOC more profitable?

Which has more volatility & risk, CTEV or TDOC?

Does the media favor CTEV or TDOC?

Do analysts prefer CTEV or TDOC?

Summary

How does Claritev compare to HealthStream?

Which has more volatility and risk, HSTM or CTEV?

Is HSTM or CTEV more profitable?

Which has stronger valuation & earnings, HSTM or CTEV?

Does the media favor HSTM or CTEV?

Do analysts recommend HSTM or CTEV?

Do institutionals & insiders believe in HSTM or CTEV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CTEV vs. The Competition

Claritev Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools